Uncategorised - European Medical Journal

New Trial Shows TENS Improves Pain in Fibromyalgia

Cluster trial shows TENS improves fibromyalgia pain with meaningful reductions sustained over six months and high patient satisfaction rates.

Hospital leadership team reviewing service pressures and crisis response planning in a clinical setting

Hospital Crisis Decision-Making Carries Hidden Risks

A qualitative study suggests hospital crisis decision-making can sideline routine care, while strengthening preparedness for later emergencies.

RAS inhibitors: risks after eGFR decline - EMJ

Stopping RAS Inhibitors After eGFR Fall May Increase Risk

Stopping RAS inhibitors after an eGFR decline may increase risk of kidney failure and death, according to a large cohort study.

Rapid Test Detects Acute Respiratory Distress Syndrome Subtypes

Rapid testing identifies acute respiratory distress syndrome subtypes linked to mortality, supporting precision medicine in critical care.

Doctor comforting a patient by placing his hand over the patient's hand.

Lupus Nephritis Biomarkers Still Face Barriers

Lupus nephritis biomarkers remain a major area of interest, but few currently show enough evidence to reflect kidney histopathology and support clinical use.

Umbilical Cord Antiseptics May Reduce Neonatal Mortality

Topical application of 4.0% chlorhexidine to the umbilical cord may reduce neonatal mortality in low- and middle-income countries, a 2026 review has found.

Doctor examining a patient's lungs using a stethoscope.

How Hospital-Acquired Pneumonia Care Is Changing

Hospital-acquired pneumonia remains a lethal ICU threat, but its diagnosis and management are entering a more precise era.

GI Challenges in Parkinson’s Disease

Parkinson’s disease (PD) affects at least 1% of people aged over 60 years and 2–3% of those aged over 65 years. PD is reported to be the…

World map with the Middle East highlight with a red glowing dot

Supply chains and trials hit by Middle East instability

Pharma companies are facing renewed pressure due to instability linked to the Middle East conflict.

Doctor with white gloves inspecting a patient's scalp.

Deucravacitinib Shows Strong Scalp Psoriasis Results

Deucravacitinib showed strong short-term psoriasis responses and excellent scalp clearance in real-world clinical practice.